Lawrence Weiss

NeoGenomics announced the appointment of Lawrence Weiss as chief scientific officer. Weiss has served as medical director and laboratory director for NeoGenomics since joining the company as part of the Clarient Diagnostic Services acquisition of 2015. As chief scientific officer, he is responsible for driving NeoGenomics scientific innovation initiatives and advancing the company's reputation in the oncology diagnostics community. Prior to joining NeoGenomics, Weiss served as laboratory director for Clarient and as chairman of the department of pathology and director of laboratories for the City of Hope National Medical Center.